VANCOUVER, British Columbia (AP) _ ESSA Pharma Inc. (EPIX) on Thursday reported fiscal fourth-quarter net income of $1 million, after reporting a loss in the same period a year earlier.
The Vancouver, British Columbia-based company said it had profit of 7 cents per share. Losses, adjusted for gains related to mergers and acquisitions, were 6 cents per share.
For the year, the company reported that its loss narrowed to $10.4 million, or $1.24 per share.
ESSA Pharma shares have more than doubled since the beginning of the year. In the final minutes of trading on Thursday, shares hit $5.50, more than doubling in the last 12 months.